MedTrace Logo

Artificial Intelligence-enable Electrocardiogram for Diagnosis and Outcome in Hyperthyroidism

NCT05675670 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35000

Last updated 2023-03-23

No results posted yet for this study

Summary

hyperthyroidism

Conditions

  • Hyperthyroidism

Interventions

OTHER

AI-enabled ECG-based Screening Tool

Primary care clinicians in the intervention group had access to the report, which displayed whether the AI-ECG result was positive or negative. The system will send a message to corresponding physicians if positive finding.

Sponsors & Collaborators

  • National Defense Medical Center, Taiwan

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2023-12-31
Completion
2024-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05675670 on ClinicalTrials.gov